KaliVir Immunotherapeutics
Megan Seippel has a diverse work experience in various roles and organizations. Megan started their career as a Program Coordinator at the University of Pittsburgh in 2002 and worked in this role until 2013. Then, they transitioned to become a Grants Administrator at the same university from June 2019 to June 2020. In 2021, Megan joined Nurix Therapeutics where they worked in Operations until May 2023. Currently, they are the Laboratory Operations Manager at KaliVir Immunotherapeutics starting from May 2023.
Megan Seippel holds a Masters of Public Administration from the University of Pittsburgh.
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells